NHS Logo
As One Logo

8. Substance dependence

8.1 Alcohol dependence

Alcohol dependence Preparations Comments
The drugs listed below are for the acute/initial management of alcohol dependence and withdrawal. For longer term management and relapse prevention service users should be referred to CDAT service run by CRI.
Chlordiazepoxide 5mg capsules or tablets  See chlordiazepoxide for alcohol withdrawal regime
Thiamine 50mg and 100mg tablets  
Vitamin B Co strong Tablets  
High potency vitamin B complex (Pabrinex) IM injection For in-patient use.
Facilities for treating anaphylaxis (including resuscitation facilities should be available when parenteral thiamine is administered.

 8.2 Nicotine dependence

 Nicotine dependence Preparations Comments
Nicotine Transdermal patch: Nicorette® Inivsi Patches 25mg, 15mg and 10mg
Lozenges:NiQuitin® Minis Lozenges 1.5mg and 4mg
Inhalation vapour: Nicorette® Inhalator 15mg cartridgesOrodispersible film (strips): NiQuitin® 2.5mg oral filmSublingual tablet: Nicorette® Microtab 2mgNasal spray:  Nicorette®  500 microgram per actuationMouth spray: Nicorette® Quickmist 1mg per actuation
See HPFT Nicotine Replacement Therapy Policy for Inpatients
Varenicline tartrate 500microgram and 1mg tablet. NICE -TA123 - Varenicline for smoking cessation               Named patient request only

 8.3 Opioid dependence

Opioid dependence Preparations Comments
Treatment of opioid dependence usually requires specialist intervention - generalists who do not have specialist experience should contact Community drugs and alcohol services (CGL) for advice before attempting to treat opioid dependence.
NICE -TA114 - Methadone and buprenorphine for the management of opioid dependence
Buprenorphine hydrochloride

400microgram, 2mg and 8mg sublingual tablets             

2mg and 8mg oral lyophilisate tablets (Espranor)

CD. Only in accordance with specialist recommendations.
Methadone hydrochloride 1mg/ml SF oral solution CD. Only in accordance with specialist recommendations.


Continue to BNF Chapter 5


Back to BNF Chapter 4

Back to Contents Page


Contact Us